Results 81 to 90 of about 48,908 (228)

Severe Thrombocytopenia With Wet Purpura in Brucellosis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Brucellosis is a zoonotic infection that passes to humans from infected animals via direct contact or the intake of raw milk and its products. The hematologic profile most frequently seen in acute brucellosis includes mild anemia and leukopenia. Severe form of thrombocytopenia and multiple wet purpura over the tongue and buccal mucosa are less
Fatemeh Ravanbakhsh Ghavghani   +2 more
wiley   +1 more source

Synergism of Linezolid and Rifampin to Combat Multidrug-Resistant Environmental Enterococci Isolates

open access: yesپیاورد سلامت, 2022
Background and Aim: Wastewater is one of the most dangerous and important sources of pathogens and their treatment does not always guarantee the elimination of pathogenic bacteria.
Mobina Noori   +2 more
doaj  

Rifampin-Associated Thrombocytopenia Secondary to Poor Compliance

open access: yes, 1989
Rifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, hemolytic anemia, and thrombocytopenia. Thrombocytopenia has traditionally been associated with intermittent therapy.
Vu Hoang   +3 more
core   +1 more source

Isoniazid‐Related Secondary Drug‐Induced Autoimmune Hepatitis in a Patient Diagnosed With Ankylosing Spondylitis and Tuberculous Lymphadenitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Autoimmune hepatitis is a type of chronic hepatitis that is usually progressive, has unknown etiology, and can occur at any age. In the present case, drug‐associated autoimmune hepatitis (DIAIH) was discussed, and DIAIH secondary to isoniazid (INH) was found in two case reports in the literature.
Murat AY, Erhan Bozkurt
wiley   +1 more source

Tear lipocalin: potential for selective delivery of rifampin

open access: yes, 2004
The potential of ligand binding proteins as drug carriers and delivery systems has recently sparked great interest. We investigated the potential of tear lipocalin (TL) to bind the antibiotic, rifampin, and the environmental conditions for controlled ...
Glasgow, Ben J   +5 more
core   +1 more source

Contezolid in the Treatment of Multidrug‐Resistant Tuberculous Meningitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Multidrug‐resistant tuberculous meningitis (MDR‐TBM) has a high mortality rate, and treatment options are limited. Linezolid is recommended for refractory cases but often causes intolerable adverse reactions such as peripheral neuropathy. Contezolid, a novel oxazolidinone, has shown better safety profiles in preclinical and early clinical ...
Na Wang   +10 more
wiley   +1 more source

Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study

open access: yesDrug Design, Development and Therapy, 2017
Felix Greimel,1 Christine Scheuerer,1 Andre Gessner,2 Michaela Simon,2 Thomas Kalteis,1 Joachim Grifka,1 Achim Benditz,1 Hans-Robert Springorum,1 Jens Schaumburger1 1Department of Orthopedics, University Medical Center Regensburg, Asklepios ...
Greimel F   +8 more
doaj  

Activity of contezolid against methicillin-resistant Staphylococcus aureus in a rat model of foreign body osteomyelitis

open access: yesMicrobiology Spectrum
Contezolid has activity against methicillin-resistant Staphylococcus aureus (MRSA), a common cause of orthopedic infection. In a rat model of foreign body osteomyelitis, 1.3 log10 cfu/g bone and 0.5 log10 cfu/k-wire reduction in MRSA was found in tibiae (
Sebastian C. Herren   +6 more
doaj   +1 more source

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis [PDF]

open access: yes
The impact of heteroresistance on tuberculosis (TB) treatment outcomes is unclear, as is the role of different rifampin and isoniazid exposures on developing resistance mutations.
Akkerman, Onno W; id_orcid   +9 more
core   +1 more source

A Case of Atypical Delayed Anaphylaxis to Rifampin

open access: yes, 2023
Rifampin is a mainstay in anti-tuberculosis therapy and is generally well tolerated and safe to take at therapeutic dosing. While anaphylactic reactions to rifampin are exceedingly rare, prompt recognition and awareness is vital to patient safety, and ...
Jessica Sworzyn   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy